News

2017 Jan 17

Ofatumumab improves overall response in Waldenström macroglobulinemia

A study by Richard Furman, M.D., found that ofatumumab may be a non-chemotherapeutic option for patients with Waldenström macroglobulinemia. Read more

Innovation from Weill Cornell Medicine scientists + the best medical care from NewYork-Presbyterian doctors puts Meyer Cancer Center first in NYC cancer care.

2017 Jan 17

My visit to the medical Holodeck

Feature about the use of virtual reality for cancer research at Weill Cornell Medicine. Read more

2017 Jan 13

Anti-science culture is growing, say Nobel Laureates

Harold Varmus, M.D., warned against the "anti-science movement" during a visit to India for the Nobel Prize Series. Read more

2017 Jan 12

Exploring epigenetic therapy for aggressive prostate cancer

With the help of a 2016 Lori Milken–PCF Young Investigator Award from the Prostate Cancer Foundation, Loredana Puca, Ph.D., is studying the genomic characteristics of neuroendocrine prostate cancer and whether it might be possible to develop an epigenetic therapy to treat it. Read more

cervical cancer, endometrial cancer, ovarian cancer, uterine cancer, vaginal, vulvar, carcinosarcoma, leiomyosarcoma, mullerian tumors

2017 Jan 11

Weill/NYP support updated HPV vaccine recommendations

NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine are among the nation’s top healthcare institutions in supporting revised vaccination guidelines from the Centers for Disease Control and Prevention (CDC) for the human papillomavirus (HPV). Read more

Lewis Cantley, Ph.D., and Kristy Richards, M.D., Ph.D. are collaborating to combat cancer at Cornell and Weill Cornell Medicine

2017 Jan 09

'Radical collaboration' sets its sights on cancer treatment

Lewis C. Cantley, Ph.D., and Kristy Richards, Ph.D., M.D. are collaborating to revamp the ways cancer drugs can be researched, tested and approved. Read more

2017 Jan 05

Tailored organoid may help unravel immune response mystery

An Ithaca-NYC team has developed a modular immune organoid that can replicate the anatomical structures found within lymph nodes to mimic the early stages of a germinal center, where B cell differentiation and initiation of immunological responses take place during infection. Read more

2017 Jan 05

When should you be screened? Important cancer tests you shouldn't miss

Felice Schnoll-Sussman, M.D., appeared on the TODAY Show to review cancer screening guidelines by age Read more

2017 Jan 04

Copper toned research trial offers new hope in finding a cure for cancer

TV coverage of Linda Vahdat's copper depletion trial, and the crowdfunding initiative she has started to fund it. Read more

2017 Jan 04

Softening of tumor tissue could aid in cancer drug delivery

An Ithaca-NYC team has found that the stiffening of the matrix surrounding a metastatic tumor plays a key role in the vascular makeup of the tumor that promotes tumor growth and mobility by keeping drugs out. Read more

2016 Dec 29

Incidence of metastatic prostate cancer in older men increases following drop in PSA screening

The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011, according to new research from Jim Hu, M.D. Read more

2016 Dec 28

Breast center launches innovative crowdfunding campaign to fund clinical trial

Linda Vahdat, M.D., is turning to the public to help fund a trial for a new triple negative breast cancer treatment involving a simple oral medication that reduces copper levels in the patient’s body Read more

2016 Dec 24

The profound impacts of patients

Jeffrey Greenfield, M.D., Ph.D., shared his story about how one patient had a profound impact on his career. Read more

2016 Dec 22

7 Warning Signs Of A Brain Tumor You Should Know

Neurosurgeon Theodore Schwartz, M.D., shares some brain tumor symptoms. Read more

2016 Dec 21

Metabolic pathways may provide opportunity for novel therapeutic targeting in neuro-oncology

Howard Fine, M.D., discusses the investigation of metabolic pathways in brain tumors to identify potential new therapeutic targets. Read more

2016 Dec 21

Research reveals codes that control protein expression

An internal code in messenger RNA predetermines how much protein they will produce, according to a new study by Samie Jaffrey. Read more

2016 Dec 20

End-of-life discussions held at ‘astounding’ infrequency

Ninety-five percent of patients with advanced cancer have an insufficient understanding of their prognosis and are ill-equipped to make informed end-of-life care decisions, according to a study by Holly Prigerson, Ph.D., and colleagues. Read more

Robert Brown, M.D., liver transplant doctor at Weill Cornell New York Presbyterian

2016 Dec 20

New model could benefit liver cancer transplant patients

A simple blood test may better predict which patients diagnosed with liver cancer will experience disease recurrence, according to new research from Weill Cornell Medicine doctors. Read more

2016 Dec 16

New guidelines aim to standardize interpretation and reporting of somatic cancer variants

Olivier Elemento, Ph.D., comments on a new set of guidelines released by the Association for Molecular Pathology. Read more

2016 Dec 15

Corrupted tumor blood vessels spawn cancer stem cells

The tumor microenvironment can determine whether cancer cells become aggressive cancer stem cells that are resistant to treatment and cause cancers to come back after therapy, according to a new study by a team of researchers led by Shahin Rafii. Read more